- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/87 - HydrazidesThio or imino analogues thereof in position 3
Patent holdings for IPC class C07D 213/87
Total number of patents in this class: 37
10-year publication summary
|
4
|
4
|
2
|
1
|
5
|
3
|
3
|
2
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| HMI Medical Innovations, LLC | 14 |
8 |
| Theravance Biopharma R&D IP, LLC | 407 |
3 |
| F. Hoffmann-La Roche AG | 7836 |
2 |
| Bayer Cropscience AG | 1846 |
2 |
| The General Hospital Corporation | 4858 |
2 |
| Jiangsu Kanion Pharmaceutical Co., Ltd. | 92 |
2 |
| Monash University | 733 |
2 |
| The Walter and Eliza Hall Institute of Medical Research | 166 |
2 |
| Mitsui Chemicals Agro, Inc. | 79 |
1 |
| Cytokinetics, Inc. | 257 |
1 |
| Fudan University | 767 |
1 |
| Memorial Sloan-Kettering Cancer Center | 2038 |
1 |
| Musc Foundation for Research Development | 366 |
1 |
| Shandong University | 1151 |
1 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 870 |
1 |
| Shanghai Institute of Pharmaceutical Industry | 127 |
1 |
| Synta Pharmaceuticals Corp. | 146 |
1 |
| University of Utah Research Foundation | 1860 |
1 |
| Kanaph Therapeutics Inc. | 44 |
1 |
| Hibercell, Inc. | 70 |
1 |
| Other owners | 2 |